Literature DB >> 25181971

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms].

U Kiltz1, M Rudwaleit, J Sieper, D Krause, J-F Chenot, A Stallmach, S Jaresch, U Oberschelp, E Schneider, B Swoboda, H Böhm, A Heiligenhaus, U Pleyer, W-H Böhncke, M Stemmer, J Braun.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25181971     DOI： 10.1007/s00393-014-1428-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  83 in total

1.  Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis.

Authors:  H Marzo-Ortega; D McGonagle; P O'Connor; P Emery
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis.

Authors:  J M Benitez-Del-Castillo; J Garcia-Sanchez; T Iradier; A Bañares
Journal:  Eye (Lond)       Date:  2000-06       Impact factor: 3.775

3.  Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression.

Authors:  S Brophy; A Calin
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

4.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

5.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation.

Authors:  R A Deyo; P Diehr; D L Patrick
Journal:  Control Clin Trials       Date:  1991-08

6.  Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis.

Authors:  W M Brown; R Doll
Journal:  Br Med J       Date:  1965-12-04

7.  Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis.

Authors:  Nuria Montala; Xavier Juanola; Eduardo Collantes; Elisa Muñoz-Gomariz; Carlos Gonzalez; Jordi Gratacos; Pedro Zarco; Jose Luis Fernandez Sueiro; Juan Mulero; Juan Carlos Torre-Alonso; Enrique Batlle; Loreto Carmona
Journal:  J Rheumatol       Date:  2011-03-01       Impact factor: 4.666

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease.

Authors:  Carlos Gonzalez-Juanatey; Tomas R Vazquez-Rodriguez; Jose A Miranda-Filloy; Trinidad Dierssen; Ines Vaqueiro; Ricardo Blanco; Javier Martin; Javier Llorca; Miguel A Gonzalez-Gay
Journal:  Medicine (Baltimore)       Date:  2009-11       Impact factor: 1.889

10.  First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early).

Authors:  Marena Rojas-Vargas; Elisa Muñoz-Gomariz; Alejandro Escudero; Pilar Font; Pedro Zarco; Raquel Almodovar; Jordi Gratacós; Juan Mulero; Xavier Juanola; Carlos Montilla; Estefanía Moreno; Eduardo Collantes-Estevez
Journal:  Rheumatology (Oxford)       Date:  2009-02-10       Impact factor: 7.580
View more
  2 in total

Review 1.  [Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 2.  [Becoming older with axial spondyloarthritis].

Authors:  U Kiltz; X Baraliakos; B Buehring; J Braun
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.